DRAXIS Initiates Phase II Clinical Trials of INFECTON
Diagnostic radiopharmaceutical for imaging infection moves to next stage of development
06-Aug-2003 -
DRAXIMAGE Inc., the radiopharmaceutical subsidiary of DRAXIS Health Inc. has received Health Canada approval to initiate two Phase II clinical studies of INFECTON(TM), a novel radiopharmaceutical diagnostic imaging agent for detecting and determining the location of infection in patients with ...
appendicitis
bacterial infections
biotechnology
+9